Dianosic aims at resolving patient compliance challenges in respiratory care with intranasal, drug-eluting, resorbable scaffolds
Dianosic has raised $8.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Dianosic's investors include Bpifrance, Noshaq, Capital Grand Est, Finovam Gestion, Aptar Pharma.
Dianosic is headquartered in Strasbourg, France.
Dianosic aims at resolving patient compliance challenges in respiratory care with intranasal, drug-eluting, resorbable scaffolds
Dianosic is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dianosic — Funding & Investors." VCBacked, September 5, 2025, https://www.vcbacked.co/company/dianosic. Accessed July 20, 2026.
VCBacked. (2025). Dianosic — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/dianosic
{{cite web |title=Dianosic — Funding & Investors |url=https://www.vcbacked.co/company/dianosic |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated